课题基金 / 基金详情

NanoMan: Self-Optimising Nanoscale Manufacturing Platforms for Achieving Multiscale Precision

NanoMan: Self-Optimising Nanoscale Manufacturing Platforms for Achieving Multiscale Precision
NanoMan:自我优化纳米级制造平台,实现多尺度精度
批准号:
EP/V055089/1
负责人:
Nicholas Warren
金额:
$182.5万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2022
资助国家:
英国
项目状态:
未结题
起止时间:
2022 至 --

项目摘要

项目成果

Nicholas Warren的其他基金

相似基金

相关文献

中文摘要
翻译
改善我们目前的生活方式并确保不断增长的人口的健康取决于更先进的消费品的开发。许多这些工程产品具有先进的功能,由纳米尺寸的颗粒提供,比人类头发的宽度小数千倍。这些纳米颗粒的确切尺寸决定了特定应用的作用机制和性能。在医疗保健中,许多药物需要封装在聚合物纳米颗粒内,原因有几个,包括溶解不溶性药物,保护药物免受不必要的降解(例如mRNA疫苗)和提供有效的递送(抗癌药物)。在电子领域,通过控制量子点纳米颗粒的尺寸,可以对所产生的光的颜色和强度进行微调,从而产生更高质量的显示器、超薄智能涂层(例如用于可穿戴技术)、先进的诊断、高强度医学成像或高效太阳能电池板。生产这些材料所需的精度是惊人的,通常只有在专业科学家的专门研究实验室中才能重复实现。因此,在以具有成本效益或可持续的方式扩大规模方面进展甚微。 在这个项目中,我们将建立平台技术,包括以计算智能为基础的先进化学反应器,它可以扩大先进纳米颗粒产品的生产,而不会损失在研究实验室中实现的对结构尺寸的精确控制。我们将建立实验室反应器,可以编程来监测纳米粒子的形成过程中,在真实的时间和相关的条件,粒子的属性。在整个制造过程中,机器学习算法将通过条件的“自我优化”来指导反应器实现所需的规格。该项目的一个关键部分是使用实验室实验中获得的数据来建立过程和产品之间的关系,这些关系可以转移到设备上,这些设备可以在一个称为增强无损放大的过程中以商业相关的规模制造材料。我们将采用优化的实验室纳米颗粒形成工艺,并在多个制造环境中展示规模,包括我们合作伙伴的研发工艺实验室和商业制造设施。这样的演示将鼓励项目生命周期之外的进一步创新,从而实现目前仅限于研究实验室的先进材料。
英文摘要
Improving our current lifestyle and ensuring health of a growing population is reliant on the development of more advanced consumer products. Many of these engineered products have advanced functionality delivered by particles with nanometre dimensions, many thousands of times smaller than the width of a human hair. The exact size of these nanoparticles determines the mechanism of action and performance for the specific application. In healthcare, many drugs require encapsulation within polymer nanoparticles for several reasons, including for dissolving insoluble drugs, protecting drugs from unwanted degradation (e.g. mRNA vaccines) and providing efficient delivery (anti-cancer drugs). In electronics, the colour and intensity of light produced can be finely tuned by controlling the size of quantum dot nanoparticles, thus resulting in much higher quality displays, ultra-thin smart coatings (e.g. for wearable technologies), advanced diagnostics, high intensity medical imaging or high efficiency solar panels. The accuracy required to produce these materials is phenomenal and often only achieved reproducibly in dedicated research laboratories by specialist scientists. There has therefore been little progress on scaling up in a cost-effective or sustainable manner. In this project we will build platform technologies, comprising advanced chemical reactors underpinned by computational intelligence, which can scale up production of advanced nanoparticle products without loss in the precise control over structural dimensions which are achieved in research laboratories. We will build laboratory reactors which can be programmed to monitor the nanoparticle formation process in real time and relate conditions to the particle properties. Throughout the manufacturing process the machine learning algorithms will direct the reactors towards achieving the desired specification through 'self-optimisation' of conditions. A critical part of the project is then using the data obtained in the lab experiments to build a relationship between process and product which can be transferred onto equipment which can make the materials on a commercially relevant scale in a process called augmented lossless scale-up. We will take the optimised laboratory nanoparticle formation processes and demonstrate scale in several manufacturing environments, including R&D process laboratories and Commercial manufacturing facilities at our partners sites. Such demonstration will encourage further innovation beyond the lifetime of the project which can work towards realising advanced materials currently confined to research laboratories.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1109/cec53210.2023.10254023
发表时间: 2023-07
期刊: 2023 IEEE Congress on Evolutionary Computation (CEC)
影响因子: --
作者: [Jingyu Chen;John Oyekan]
通讯作者: Jingyu Chen;John Oyekan
DOI: 10.1039/d2py00040g
发表时间: 2022-02-18
期刊: POLYMER CHEMISTRY
影响因子: 4.6
作者: [Knox, Stephen T., Parkinson, Sam J., Warren, Nicholas J.]
通讯作者: Warren, Nicholas J.
DOI: 10.1021/acs.macromol.2c01798
发表时间: 2023-02-28
期刊: Macromolecules
影响因子: 5.5
作者: [Wilding CYP, Knox ST, Bourne RA, Warren NJ]
通讯作者: Warren NJ
Continuous synthesis of block copolymer nanoparticles via telescoped RAFT solution and dispersion polymerisation in a miniature CSTR cascade
通过伸缩 RAFT 溶液和微型 CSTR 级联中的分散聚合连续合成嵌段共聚物纳米颗粒
DOI: 10.1039/d2re00475e
发表时间: 2023
期刊: Reaction Chemistry & Engineering
影响因子: 3.9
作者: [Pittaway P]
通讯作者: Pittaway P
Intelligent Continuous-flow Polymer Synthesis
  • 批准号:
    EP/S000380/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $38.96万
  • 财政年份:
    2018
  • 负责人:
    Nicholas Warren
  • 依托单位:
国内基金
海外基金
Self-DNA介导的CD4+组织驻留记忆T细胞(Trm)分化异常在狼疮肾炎发病中的作用及机制研究
  • 批准号:
    82371813
  • 项目类别:
    面上项目
  • 资助金额:
    50万元
  • 批准年份:
    2023
  • 负责人:
    熊思东
  • 依托单位:
基于受体识别和转运整合的self-DNA诱导采后桃果实抗病反应的机理研究
  • 批准号:
    32302161
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    黎春红
  • 依托单位:
基于广义测量的多体量子态self-test的实验研究
  • 批准号:
    12104186
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    边志浩
  • 依托单位:
Self-shrinkers的刚性及相关问题
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2019
  • 负责人:
    魏国新
  • 依托单位: